DK1265904T3 - Positivt allosteriske AMPA-receptormodulatorer, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemidler - Google Patents

Positivt allosteriske AMPA-receptormodulatorer, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemidler

Info

Publication number
DK1265904T3
DK1265904T3 DK01911553T DK01911553T DK1265904T3 DK 1265904 T3 DK1265904 T3 DK 1265904T3 DK 01911553 T DK01911553 T DK 01911553T DK 01911553 T DK01911553 T DK 01911553T DK 1265904 T3 DK1265904 T3 DK 1265904T3
Authority
DK
Denmark
Prior art keywords
drugs
preparing
methods
receptor modulators
positive allosteric
Prior art date
Application number
DK01911553T
Other languages
Danish (da)
English (en)
Inventor
Karin Winter
Thomas Weiser
Stefan Matthias Blech
Angelo Ceci
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1265904T3 publication Critical patent/DK1265904T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK01911553T 2000-02-02 2001-01-30 Positivt allosteriske AMPA-receptormodulatorer, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemidler DK1265904T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10004572A DE10004572A1 (de) 2000-02-02 2000-02-02 Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
PCT/EP2001/000960 WO2001057045A1 (fr) 2000-02-02 2001-01-30 Nouveaux modulateurs (paarm) allosteriques positifs de recepteurs ampa, leur methode de production et leur utilisation comme medicaments

Publications (1)

Publication Number Publication Date
DK1265904T3 true DK1265904T3 (da) 2004-10-25

Family

ID=7629599

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01911553T DK1265904T3 (da) 2000-02-02 2001-01-30 Positivt allosteriske AMPA-receptormodulatorer, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemidler

Country Status (16)

Country Link
US (3) US6525045B2 (fr)
EP (1) EP1265904B1 (fr)
JP (1) JP4891510B2 (fr)
AR (1) AR027352A1 (fr)
AT (1) ATE277054T1 (fr)
AU (1) AU2001240561A1 (fr)
CA (1) CA2399377C (fr)
CO (1) CO5261505A1 (fr)
DE (2) DE10004572A1 (fr)
DK (1) DK1265904T3 (fr)
ES (1) ES2228817T3 (fr)
MX (1) MXPA02007460A (fr)
PT (1) PT1265904E (fr)
TR (1) TR200402650T4 (fr)
UY (1) UY26566A1 (fr)
WO (1) WO2001057045A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10004572A1 (de) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7071184B2 (en) * 2000-03-21 2006-07-04 Smithkline Beecham Corporation Protease inhibitors
NZ529308A (en) * 2001-04-05 2005-03-24 Collagenex Pharm Inc Tetracycline compounds comprising a tetracycline and a controlled release agent to provide delivery at a dose below that required for antibiotic activity
US20030100552A1 (en) 2001-05-17 2003-05-29 Boehringer Ingelheim Pharma Kg Positive allosteric AMPA receptor modulators (PAARM), processes for preparing them, and their use as pharmaceutical compositions
DE10123952A1 (de) * 2001-05-17 2002-11-21 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
CA2458388A1 (fr) 2001-10-10 2003-04-17 Neurosearch A/S Nouveaux derives de benzothiazine, leur preparation et leur utilisation
US7815391B2 (en) * 2004-07-23 2010-10-19 Kauppila Richard W Structural member joints
US20060063707A1 (en) * 2004-09-17 2006-03-23 Lifelike Biomatic, Inc. Compositions for enhancing memory and methods therefor
AU2009243730B2 (en) * 2008-05-05 2013-07-18 Polypeptide Laboratories Holding (Ppl) Ab Indolesulfonyl protecting groups for protection of guanidino and amino groups
US20110218190A1 (en) * 2008-11-10 2011-09-08 The Regents Of The University Of California Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction
EP3311842A1 (fr) 2013-06-13 2018-04-25 VeroScience LLC Compositions et procédés de traitement des troubles métaboliques

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724566D0 (en) * 1987-10-20 1987-11-25 Roussel Lab Ltd Chemical compounds
US4994452A (en) * 1989-11-28 1991-02-19 Hoechst-Roussel Pharmaceuticals Inc. Hexahydro-1H-quino[4,3,2-ef][1,4]benzoxazepines and related compounds
AU3957093A (en) * 1992-04-15 1993-11-18 Rhone-Poulenc Rorer S.A. 3,4-dihydro-2H-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxyl ic acid derivatives, preparation thereof and drugs containing same
BR9507672A (pt) * 1994-05-24 1997-08-19 Hoffmann La Roche Derivados tricíclicos de dicarbonila
US5891871A (en) * 1996-03-21 1999-04-06 Cocensys, Inc. Substituted 2,3-benzodiazepin-4-ones and the use thereof
AU4345297A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
US5968928A (en) * 1996-09-19 1999-10-19 Warner-Lambert Company Excitatory amino acid antagonists: fused-azacyclic quinoxalinediones and immunoassays thereof
US5969138A (en) * 1996-11-01 1999-10-19 Mitsui Chemicals, Inc. Pyrrolidinone derivatives
US5985871A (en) * 1997-12-24 1999-11-16 Cortex Pharmaceuticals, Inc. Benzoxazine compounds for enhancing synaptic response
CA2320354A1 (fr) * 1998-02-18 1999-08-26 Neurosearch A/S Nouveaux composes et leur utilisation comme modulateurs positifs du recepteur ampa
US6096744A (en) * 1998-05-04 2000-08-01 Warner-Lambert Company Sulfonamide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
DE10004572A1 (de) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
JP2003522180A (ja) 2003-07-22
UY26566A1 (es) 2001-08-27
CO5261505A1 (es) 2003-03-31
US6800623B2 (en) 2004-10-05
CA2399377A1 (fr) 2001-08-09
DE10004572A1 (de) 2001-08-09
ES2228817T3 (es) 2005-04-16
ATE277054T1 (de) 2004-10-15
EP1265904A1 (fr) 2002-12-18
TR200402650T4 (tr) 2004-11-22
DE50103760D1 (de) 2004-10-28
EP1265904B1 (fr) 2004-09-22
MXPA02007460A (es) 2003-01-28
US6525045B2 (en) 2003-02-25
US20020013313A1 (en) 2002-01-31
CA2399377C (fr) 2008-12-16
PT1265904E (pt) 2004-11-30
AU2001240561A1 (en) 2001-08-14
US20030158181A1 (en) 2003-08-21
WO2001057045A1 (fr) 2001-08-09
JP4891510B2 (ja) 2012-03-07
US20030158183A1 (en) 2003-08-21
AR027352A1 (es) 2003-03-26

Similar Documents

Publication Publication Date Title
DK1294682T3 (da) Acylphenylurinstofderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
DK1218341T3 (da) Sulfonylcarboxamid-derivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
NO20032733L (no) Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse
NO20051042L (no) Pyrimidylsulfonamidderivater som kemokinreseptormodulatorer
NO20021719D0 (no) 6-posisjon substituerte indoliner, fremstilling og anvendelse derav som medikament
NO20052995D0 (no) 1,5-diaryl-pyrrol-3-karboksamid-derivater, og deres anvendelse som kannabinoid reseptormodulatorer.
NO20035298D0 (no) CDK-inhiberende pyrimider, deres fremstilling og deres anvendelse som legemidler
NO20054220D0 (no) Substituerte N-arylheterocykler, fremgangsmate for fremstilling derav og deres anvendelse som legemiddel
DK0966454T3 (da) Disubstituerede bicykliske heterocykler, deres fremstilling og deres anvendelse som lægemidler
NO20052496D0 (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter.
NO20021689L (no) 5-leddede heterocykliske derivater, fremstilling derav og anvendelse som medikamenter
DK1083171T3 (da) Pyrazolinderivater, deres fremstilling og anvendelse som medikamenter
DK1202965T3 (da) Indolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende disse og deres medicinske anvendelse
DK1095025T3 (da) Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
NO20042084L (no) 6-hydroksyisoflavoner, derivater og legemidler som omfatter disse
DK1445252T3 (da) Sulfonamid-derivater, deres fremstilling og anvendelse som medikamenter
NO20020314L (no) 2-arylimino-2,3-dihydrotiazoler og deres anvendelse som ligander for somatostatin-reseptorer
NO20005146L (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
ZA200210293B (en) Allosteric Adenosine Receptor Modulators.
NO20024749D0 (no) Indolin-2-on-derivater, deres fremstilling og anvendelse som ocytocin reseptor ligander
DK1322158T3 (da) Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf
DK1265904T3 (da) Positivt allosteriske AMPA-receptormodulatorer, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemidler
DK1098891T3 (da) Polycycliske thiazolidin-2-yliden-aminer, fremgangsmåde til fremstilling deraf og deres anvendelse som lægemidler
DK1053224T3 (da) Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel
DK1086077T3 (da) Hidtil ukendte antiestrogener, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse